Global Antiretroviral Therapy Market Insights and Forecast to 2028

Publisher Name :
Date: 07-Apr-2022
No. of pages: 89
Inquire Before Buying

Antiretroviral Therapy market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Antiretroviral Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- NNRTIs

- NRTI

- Multiclass Combination Products

- Integrase Inhibitors

Segment by Application

- Hospital

- Clinic

- Other

By Company

- Gilead

- F. Hoffmann-La Roche

- ViiV Healthcare

- Boehringer Ingelheim

- Janssen Pharmaceuticals

- Mylan

- Abbvie

- Bionor Pharma

- Vertex Pharmaceuticals

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Global Antiretroviral Therapy Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Antiretroviral Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Antiretroviral Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 NNRTIs
1.2.3 NRTI
1.2.4 Multiclass Combination Products
1.2.5 Integrase Inhibitors
1.3 Market by Application
1.3.1 Global Antiretroviral Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antiretroviral Therapy Sales Estimates and Forecasts 2017-2028
2.2 Global Antiretroviral Therapy Revenue Estimates and Forecasts 2017-2028
2.3 Global Antiretroviral Therapy Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antiretroviral Therapy Sales by Region
2.4.1 Global Antiretroviral Therapy Sales by Region (2017-2022)
2.4.2 Global Sales Antiretroviral Therapy by Region (2023-2028)
2.5 Global Antiretroviral Therapy Revenue by Region
2.5.1 Global Antiretroviral Therapy Revenue by Region (2017-2022)
2.5.2 Global Antiretroviral Therapy Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antiretroviral Therapy Sales by Manufacturers
3.1.1 Global Top Antiretroviral Therapy Manufacturers by Sales (2017-2022)
3.1.2 Global Antiretroviral Therapy Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antiretroviral Therapy in 2021
3.2 Global Antiretroviral Therapy Revenue by Manufacturers
3.2.1 Global Antiretroviral Therapy Revenue by Manufacturers (2017-2022)
3.2.2 Global Antiretroviral Therapy Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Antiretroviral Therapy Revenue in 2021
3.3 Global Antiretroviral Therapy Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antiretroviral Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antiretroviral Therapy Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antiretroviral Therapy Sales by Type
4.1.1 Global Antiretroviral Therapy Historical Sales by Type (2017-2022)
4.1.2 Global Antiretroviral Therapy Forecasted Sales by Type (2023-2028)
4.1.3 Global Antiretroviral Therapy Sales Market Share by Type (2017-2028)
4.2 Global Antiretroviral Therapy Revenue by Type
4.2.1 Global Antiretroviral Therapy Historical Revenue by Type (2017-2022)
4.2.2 Global Antiretroviral Therapy Forecasted Revenue by Type (2023-2028)
4.2.3 Global Antiretroviral Therapy Revenue Market Share by Type (2017-2028)
4.3 Global Antiretroviral Therapy Price by Type
4.3.1 Global Antiretroviral Therapy Price by Type (2017-2022)
4.3.2 Global Antiretroviral Therapy Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Antiretroviral Therapy Sales by Application
5.1.1 Global Antiretroviral Therapy Historical Sales by Application (2017-2022)
5.1.2 Global Antiretroviral Therapy Forecasted Sales by Application (2023-2028)
5.1.3 Global Antiretroviral Therapy Sales Market Share by Application (2017-2028)
5.2 Global Antiretroviral Therapy Revenue by Application
5.2.1 Global Antiretroviral Therapy Historical Revenue by Application (2017-2022)
5.2.2 Global Antiretroviral Therapy Forecasted Revenue by Application (2023-2028)
5.2.3 Global Antiretroviral Therapy Revenue Market Share by Application (2017-2028)
5.3 Global Antiretroviral Therapy Price by Application
5.3.1 Global Antiretroviral Therapy Price by Application (2017-2022)
5.3.2 Global Antiretroviral Therapy Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antiretroviral Therapy Market Size by Type
6.1.1 North America Antiretroviral Therapy Sales by Type (2017-2028)
6.1.2 North America Antiretroviral Therapy Revenue by Type (2017-2028)
6.2 North America Antiretroviral Therapy Market Size by Application
6.2.1 North America Antiretroviral Therapy Sales by Application (2017-2028)
6.2.2 North America Antiretroviral Therapy Revenue by Application (2017-2028)
6.3 North America Antiretroviral Therapy Market Size by Country
6.3.1 North America Antiretroviral Therapy Sales by Country (2017-2028)
6.3.2 North America Antiretroviral Therapy Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Antiretroviral Therapy Market Size by Type
7.1.1 Europe Antiretroviral Therapy Sales by Type (2017-2028)
7.1.2 Europe Antiretroviral Therapy Revenue by Type (2017-2028)
7.2 Europe Antiretroviral Therapy Market Size by Application
7.2.1 Europe Antiretroviral Therapy Sales by Application (2017-2028)
7.2.2 Europe Antiretroviral Therapy Revenue by Application (2017-2028)
7.3 Europe Antiretroviral Therapy Market Size by Country
7.3.1 Europe Antiretroviral Therapy Sales by Country (2017-2028)
7.3.2 Europe Antiretroviral Therapy Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antiretroviral Therapy Market Size by Type
8.1.1 Asia Pacific Antiretroviral Therapy Sales by Type (2017-2028)
8.1.2 Asia Pacific Antiretroviral Therapy Revenue by Type (2017-2028)
8.2 Asia Pacific Antiretroviral Therapy Market Size by Application
8.2.1 Asia Pacific Antiretroviral Therapy Sales by Application (2017-2028)
8.2.2 Asia Pacific Antiretroviral Therapy Revenue by Application (2017-2028)
8.3 Asia Pacific Antiretroviral Therapy Market Size by Region
8.3.1 Asia Pacific Antiretroviral Therapy Sales by Region (2017-2028)
8.3.2 Asia Pacific Antiretroviral Therapy Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Antiretroviral Therapy Market Size by Type
9.1.1 Latin America Antiretroviral Therapy Sales by Type (2017-2028)
9.1.2 Latin America Antiretroviral Therapy Revenue by Type (2017-2028)
9.2 Latin America Antiretroviral Therapy Market Size by Application
9.2.1 Latin America Antiretroviral Therapy Sales by Application (2017-2028)
9.2.2 Latin America Antiretroviral Therapy Revenue by Application (2017-2028)
9.3 Latin America Antiretroviral Therapy Market Size by Country
9.3.1 Latin America Antiretroviral Therapy Sales by Country (2017-2028)
9.3.2 Latin America Antiretroviral Therapy Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antiretroviral Therapy Market Size by Type
10.1.1 Middle East and Africa Antiretroviral Therapy Sales by Type (2017-2028)
10.1.2 Middle East and Africa Antiretroviral Therapy Revenue by Type (2017-2028)
10.2 Middle East and Africa Antiretroviral Therapy Market Size by Application
10.2.1 Middle East and Africa Antiretroviral Therapy Sales by Application (2017-2028)
10.2.2 Middle East and Africa Antiretroviral Therapy Revenue by Application (2017-2028)
10.3 Middle East and Africa Antiretroviral Therapy Market Size by Country
10.3.1 Middle East and Africa Antiretroviral Therapy Sales by Country (2017-2028)
10.3.2 Middle East and Africa Antiretroviral Therapy Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Gilead
11.1.1 Gilead Corporation Information
11.1.2 Gilead Overview
11.1.3 Gilead Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Gilead Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Gilead Recent Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Corporation Information
11.2.2 F. Hoffmann-La Roche Overview
11.2.3 F. Hoffmann-La Roche Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 F. Hoffmann-La Roche Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 F. Hoffmann-La Roche Recent Developments
11.3 ViiV Healthcare
11.3.1 ViiV Healthcare Corporation Information
11.3.2 ViiV Healthcare Overview
11.3.3 ViiV Healthcare Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 ViiV Healthcare Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 ViiV Healthcare Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Corporation Information
11.4.2 Boehringer Ingelheim Overview
11.4.3 Boehringer Ingelheim Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Boehringer Ingelheim Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Boehringer Ingelheim Recent Developments
11.5 Janssen Pharmaceuticals
11.5.1 Janssen Pharmaceuticals Corporation Information
11.5.2 Janssen Pharmaceuticals Overview
11.5.3 Janssen Pharmaceuticals Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Janssen Pharmaceuticals Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Janssen Pharmaceuticals Recent Developments
11.6 Mylan
11.6.1 Mylan Corporation Information
11.6.2 Mylan Overview
11.6.3 Mylan Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Mylan Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Mylan Recent Developments
11.7 Abbvie
11.7.1 Abbvie Corporation Information
11.7.2 Abbvie Overview
11.7.3 Abbvie Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Abbvie Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Abbvie Recent Developments
11.8 Bionor Pharma
11.8.1 Bionor Pharma Corporation Information
11.8.2 Bionor Pharma Overview
11.8.3 Bionor Pharma Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bionor Pharma Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bionor Pharma Recent Developments
11.9 Vertex Pharmaceuticals
11.9.1 Vertex Pharmaceuticals Corporation Information
11.9.2 Vertex Pharmaceuticals Overview
11.9.3 Vertex Pharmaceuticals Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Vertex Pharmaceuticals Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Vertex Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antiretroviral Therapy Industry Chain Analysis
12.2 Antiretroviral Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antiretroviral Therapy Production Mode & Process
12.4 Antiretroviral Therapy Sales and Marketing
12.4.1 Antiretroviral Therapy Sales Channels
12.4.2 Antiretroviral Therapy Distributors
12.5 Antiretroviral Therapy Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antiretroviral Therapy Industry Trends
13.2 Antiretroviral Therapy Market Drivers
13.3 Antiretroviral Therapy Market Challenges
13.4 Antiretroviral Therapy Market Restraints
14 Key Findings in The Global Antiretroviral Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Antiretroviral Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of NNRTIs
Table 3. Major Manufacturers of NRTI
Table 4. Major Manufacturers of Multiclass Combination Products
Table 5. Major Manufacturers of Integrase Inhibitors
Table 6. Global Antiretroviral Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Antiretroviral Therapy Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Antiretroviral Therapy Sales by Region (2017-2022) & (KG)
Table 9. Global Antiretroviral Therapy Sales Market Share by Region (2017-2022)
Table 10. Global Antiretroviral Therapy Sales by Region (2023-2028) & (KG)
Table 11. Global Antiretroviral Therapy Sales Market Share by Region (2023-2028)
Table 12. Global Antiretroviral Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Antiretroviral Therapy Revenue Market Share by Region (2017-2022)
Table 14. Global Antiretroviral Therapy Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Antiretroviral Therapy Revenue Market Share by Region (2023-2028)
Table 16. Global Antiretroviral Therapy Sales by Manufacturers (2017-2022) & (KG)
Table 17. Global Antiretroviral Therapy Sales Share by Manufacturers (2017-2022)
Table 18. Global Antiretroviral Therapy Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Antiretroviral Therapy Revenue Share by Manufacturers (2017-2022)
Table 20. Antiretroviral Therapy Price by Manufacturers (2017-2022) &(USD/KG)
Table 21. Global Antiretroviral Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Antiretroviral Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiretroviral Therapy as of 2021)
Table 23. Antiretroviral Therapy Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Antiretroviral Therapy Product Offered
Table 25. Date of Manufacturers Enter into Antiretroviral Therapy Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Antiretroviral Therapy Sales by Type (2017-2022) & (KG)
Table 28. Global Antiretroviral Therapy Sales by Type (2023-2028) & (KG)
Table 29. Global Antiretroviral Therapy Sales Share by Type (2017-2022)
Table 30. Global Antiretroviral Therapy Sales Share by Type (2023-2028)
Table 31. Global Antiretroviral Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Antiretroviral Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Antiretroviral Therapy Revenue Share by Type (2017-2022)
Table 34. Global Antiretroviral Therapy Revenue Share by Type (2023-2028)
Table 35. Antiretroviral Therapy Price by Type (2017-2022) & (USD/KG)
Table 36. Global Antiretroviral Therapy Price Forecast by Type (2023-2028) & (USD/KG)
Table 37. Global Antiretroviral Therapy Sales by Application (2017-2022) & (KG)
Table 38. Global Antiretroviral Therapy Sales by Application (2023-2028) & (KG)
Table 39. Global Antiretroviral Therapy Sales Share by Application (2017-2022)
Table 40. Global Antiretroviral Therapy Sales Share by Application (2023-2028)
Table 41. Global Antiretroviral Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Antiretroviral Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Antiretroviral Therapy Revenue Share by Application (2017-2022)
Table 44. Global Antiretroviral Therapy Revenue Share by Application (2023-2028)
Table 45. Antiretroviral Therapy Price by Application (2017-2022) & (USD/KG)
Table 46. Global Antiretroviral Therapy Price Forecast by Application (2023-2028) & (USD/KG)
Table 47. North America Antiretroviral Therapy Sales by Type (2017-2022) & (KG)
Table 48. North America Antiretroviral Therapy Sales by Type (2023-2028) & (KG)
Table 49. North America Antiretroviral Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Antiretroviral Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Antiretroviral Therapy Sales by Application (2017-2022) & (KG)
Table 52. North America Antiretroviral Therapy Sales by Application (2023-2028) & (KG)
Table 53. North America Antiretroviral Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Antiretroviral Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Antiretroviral Therapy Sales by Country (2017-2022) & (KG)
Table 56. North America Antiretroviral Therapy Sales by Country (2023-2028) & (KG)
Table 57. North America Antiretroviral Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Antiretroviral Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Antiretroviral Therapy Sales by Type (2017-2022) & (KG)
Table 60. Europe Antiretroviral Therapy Sales by Type (2023-2028) & (KG)
Table 61. Europe Antiretroviral Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Antiretroviral Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Antiretroviral Therapy Sales by Application (2017-2022) & (KG)
Table 64. Europe Antiretroviral Therapy Sales by Application (2023-2028) & (KG)
Table 65. Europe Antiretroviral Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Antiretroviral Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Antiretroviral Therapy Sales by Country (2017-2022) & (KG)
Table 68. Europe Antiretroviral Therapy Sales by Country (2023-2028) & (KG)
Table 69. Europe Antiretroviral Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Antiretroviral Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Antiretroviral Therapy Sales by Type (2017-2022) & (KG)
Table 72. Asia Pacific Antiretroviral Therapy Sales by Type (2023-2028) & (KG)
Table 73. Asia Pacific Antiretroviral Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Antiretroviral Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Antiretroviral Therapy Sales by Application (2017-2022) & (KG)
Table 76. Asia Pacific Antiretroviral Therapy Sales by Application (2023-2028) & (KG)
Table 77. Asia Pacific Antiretroviral Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Antiretroviral Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Antiretroviral Therapy Sales by Region (2017-2022) & (KG)
Table 80. Asia Pacific Antiretroviral Therapy Sales by Region (2023-2028) & (KG)
Table 81. Asia Pacific Antiretroviral Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Antiretroviral Therapy Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Antiretroviral Therapy Sales by Type (2017-2022) & (KG)
Table 84. Latin America Antiretroviral Therapy Sales by Type (2023-2028) & (KG)
Table 85. Latin America Antiretroviral Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Antiretroviral Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Antiretroviral Therapy Sales by Application (2017-2022) & (KG)
Table 88. Latin America Antiretroviral Therapy Sales by Application (2023-2028) & (KG)
Table 89. Latin America Antiretroviral Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Antiretroviral Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Antiretroviral Therapy Sales by Country (2017-2022) & (KG)
Table 92. Latin America Antiretroviral Therapy Sales by Country (2023-2028) & (KG)
Table 93. Latin America Antiretroviral Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Antiretroviral Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Antiretroviral Therapy Sales by Type (2017-2022) & (KG)
Table 96. Middle East and Africa Antiretroviral Therapy Sales by Type (2023-2028) & (KG)
Table 97. Middle East and Africa Antiretroviral Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Antiretroviral Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Antiretroviral Therapy Sales by Application (2017-2022) & (KG)
Table 100. Middle East and Africa Antiretroviral Therapy Sales by Application (2023-2028) & (KG)
Table 101. Middle East and Africa Antiretroviral Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Antiretroviral Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Antiretroviral Therapy Sales by Country (2017-2022) & (KG)
Table 104. Middle East and Africa Antiretroviral Therapy Sales by Country (2023-2028) & (KG)
Table 105. Middle East and Africa Antiretroviral Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Antiretroviral Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 107. Gilead Corporation Information
Table 108. Gilead Description and Major Businesses
Table 109. Gilead Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 110. Gilead Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Gilead Recent Developments
Table 112. F. Hoffmann-La Roche Corporation Information
Table 113. F. Hoffmann-La Roche Description and Major Businesses
Table 114. F. Hoffmann-La Roche Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 115. F. Hoffmann-La Roche Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. F. Hoffmann-La Roche Recent Developments
Table 117. ViiV Healthcare Corporation Information
Table 118. ViiV Healthcare Description and Major Businesses
Table 119. ViiV Healthcare Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 120. ViiV Healthcare Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. ViiV Healthcare Recent Developments
Table 122. Boehringer Ingelheim Corporation Information
Table 123. Boehringer Ingelheim Description and Major Businesses
Table 124. Boehringer Ingelheim Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 125. Boehringer Ingelheim Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Boehringer Ingelheim Recent Developments
Table 127. Janssen Pharmaceuticals Corporation Information
Table 128. Janssen Pharmaceuticals Description and Major Businesses
Table 129. Janssen Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 130. Janssen Pharmaceuticals Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Janssen Pharmaceuticals Recent Developments
Table 132. Mylan Corporation Information
Table 133. Mylan Description and Major Businesses
Table 134. Mylan Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 135. Mylan Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Mylan Recent Developments
Table 137. Abbvie Corporation Information
Table 138. Abbvie Description and Major Businesses
Table 139. Abbvie Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 140. Abbvie Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Abbvie Recent Developments
Table 142. Bionor Pharma Corporation Information
Table 143. Bionor Pharma Description and Major Businesses
Table 144. Bionor Pharma Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 145. Bionor Pharma Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Bionor Pharma Recent Developments
Table 147. Vertex Pharmaceuticals Corporation Information
Table 148. Vertex Pharmaceuticals Description and Major Businesses
Table 149. Vertex Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 150. Vertex Pharmaceuticals Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Vertex Pharmaceuticals Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Antiretroviral Therapy Distributors List
Table 155. Antiretroviral Therapy Customers List
Table 156. Antiretroviral Therapy Market Trends
Table 157. Antiretroviral Therapy Market Drivers
Table 158. Antiretroviral Therapy Market Challenges
Table 159. Antiretroviral Therapy Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiretroviral Therapy Product Picture
Figure 3. Global Antiretroviral Therapy Market Share by Type in 2021 & 2028
Figure 3. NNRTIs Product Picture
Figure 4. NRTI Product Picture
Figure 5. Multiclass Combination Products Product Picture
Figure 6. Integrase Inhibitors Product Picture
Figure 7. Global Antiretroviral Therapy Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Antiretroviral Therapy Report Years Considered
Figure 12. Global Antiretroviral Therapy Sales 2017-2028 (KG)
Figure 13. Global Antiretroviral Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Antiretroviral Therapy Revenue 2017-2028 (US$ Million)
Figure 15. Global Antiretroviral Therapy Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Antiretroviral Therapy Sales Market Share by Region (2017-2022)
Figure 17. Global Antiretroviral Therapy Sales Market Share by Region (2023-2028)
Figure 18. North America Antiretroviral Therapy Sales YoY (2017-2028) & (KG)
Figure 19. North America Antiretroviral Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Antiretroviral Therapy Sales YoY (2017-2028) & (KG)
Figure 21. Europe Antiretroviral Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Antiretroviral Therapy Sales YoY (2017-2028) & (KG)
Figure 23. Asia-Pacific Antiretroviral Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Antiretroviral Therapy Sales YoY (2017-2028) & (KG)
Figure 25. Latin America Antiretroviral Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Antiretroviral Therapy Sales YoY (2017-2028) & (KG)
Figure 27. Middle East & Africa Antiretroviral Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Antiretroviral Therapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Antiretroviral Therapy in the World: Market Share by Antiretroviral Therapy Revenue in 2021
Figure 30. Global Antiretroviral Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Antiretroviral Therapy Sales Market Share by Type (2017-2028)
Figure 32. Global Antiretroviral Therapy Revenue Market Share by Type (2017-2028)
Figure 33. Global Antiretroviral Therapy Sales Market Share by Application (2017-2028)
Figure 34. Global Antiretroviral Therapy Revenue Market Share by Application (2017-2028)
Figure 35. North America Antiretroviral Therapy Sales Market Share by Type (2017-2028)
Figure 36. North America Antiretroviral Therapy Revenue Market Share by Type (2017-2028)
Figure 37. North America Antiretroviral Therapy Sales Market Share by Application (2017-2028)
Figure 38. North America Antiretroviral Therapy Revenue Market Share by Application (2017-2028)
Figure 39. North America Antiretroviral Therapy Sales Share by Country (2017-2028)
Figure 40. North America Antiretroviral Therapy Revenue Share by Country (2017-2028)
Figure 41. U.S. Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Antiretroviral Therapy Sales Market Share by Type (2017-2028)
Figure 44. Europe Antiretroviral Therapy Revenue Market Share by Type (2017-2028)
Figure 45. Europe Antiretroviral Therapy Sales Market Share by Application (2017-2028)
Figure 46. Europe Antiretroviral Therapy Revenue Market Share by Application (2017-2028)
Figure 47. Europe Antiretroviral Therapy Sales Share by Country (2017-2028)
Figure 48. Europe Antiretroviral Therapy Revenue Share by Country (2017-2028)
Figure 49. Germany Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 50. France Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Antiretroviral Therapy Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Antiretroviral Therapy Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Antiretroviral Therapy Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Antiretroviral Therapy Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Antiretroviral Therapy Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Antiretroviral Therapy Revenue Share by Region (2017-2028)
Figure 60. China Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 63. India Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Antiretroviral Therapy Sales Market Share by Type (2017-2028)
Figure 70. Latin America Antiretroviral Therapy Revenue Market Sh
  • Global Antiretroviral Therapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 21-Sep-2022        Price: US 5600 Onwards        Pages: 104
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Antiretroviral Therapy manufacturers, distributors, end users, industry associations, governments' industry bureaus, indust......
  • Global Antiretroviral Therapy Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
    Published: 31-Jul-2022        Price: US 3480 Onwards        Pages: 96
    The Antiretroviral Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our (Global I......
  • Global Antiretroviral Therapy Market Insights and Forecast to 2028
    Published: 07-Apr-2022        Price: US 4900 Onwards        Pages: 89
    Antiretroviral Therapy market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Antiretroviral Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - NNRTIs - NRTI - Multiclass Combination Products - Integrase Inhibitors ......
  • United States Antiretroviral Therapy Market Report & Forecast 2021-2027
    Published: 25-Nov-2021        Price: US 3400 Onwards        Pages: 93
    United States Antiretroviral Therapy Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (KG) United States Antiretroviral Therapy Market Segment Percentages, By Type, 2020 (%) - NNRTIs - NRTI - Multiclass Combination Products - Integrase Inhibitors United States Antiretroviral Therapy Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (KG) United States Antiretroviral Therapy Market Segment Percentages, By Application, 2020 (%)......
  • China Antiretroviral Therapy Market Report & Forecast 2021-2027
    Published: 03-Nov-2021        Price: US 3400 Onwards        Pages: 91
    China Antiretroviral Therapy Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (KG) China Antiretroviral Therapy Market Segment Percentages, By Type, 2020 (%) - NNRTIs - NRTI - Multiclass Combination Products - Integrase Inhibitors China Antiretroviral Therapy Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (KG) China Antiretroviral Therapy Market Segment Percentages, By Application, 2020 (%) - Hospital - Clini......
  • Global and United States Antiretroviral Therapy Market Insights, Forecast to 2027
    Published: 12-Aug-2021        Price: US 3900 Onwards        Pages: 130
    Antiretroviral Therapy market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Antiretroviral Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Ant......
  • Global Antiretroviral Therapy Sales Market Report 2021
    Published: 21-Apr-2021        Price: US 4000 Onwards        Pages: 123
    The global Antiretroviral Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antiretroviral Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - NNRTIs - NRTI - Multicla......
  • Global Antiretroviral Therapy Market Research Report 2021, Forecast to 2026
    Published: 01-Mar-2021        Price: US 2680 Onwards        Pages: 133
    Antiretroviral therapy refers to any HIV treatment that uses a combination of two or more drugs. A healthcare provider may choose to prescribe a combination of three or more drugs to improve the treatment's chance of success. The report forecast global Antiretroviral Therapy market to grow to reach xx Million USD in 2021 with a CAGR of xx% during the period of 2021-2026. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values and......
  • Global Antiretroviral Therapy Professional Survey Report 2021, Forecast to 2026
    Published: 01-Mar-2021        Price: US 3280 Onwards        Pages: 106
    Antiretroviral therapy refers to any HIV treatment that uses a combination of two or more drugs. A healthcare provider may choose to prescribe a combination of three or more drugs to improve the treatment's chance of success. The report forecast global Antiretroviral Therapy market to grow to reach xx Million USD in 2021 with a CAGR of xx% during the period of 2021-2026. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values and......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales[email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs